Investor Type | Firm |
Industries | BioTech • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Material Science • Medical Devices (& Hospital Services) • Robotics • Aerospace (& Defense) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B, Pre-seed |
Investing | United States • United Kingdom |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Catalio Capital is an investment fund that focuses on fostering innovation and driving transformation across multiple industries. With a keen interest in BioTech, Hardware, Energy, Artificial Intelligence, HealthTech, Web Security, Material Science, Medical Devices, Robotics, Aerospace, Healthcare, Consumer, and Pharmaceuticals, they embrace a diverse portfolio that spans the spectrum of cutting-edge sectors. Catalio Capital places significant value on the early stages of company development, actively participating in Seed, Series A, and Series B financings, also considering Pre-seed stage opportunities. They offer robust financial support, with investments ranging from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot of around $1,500,000 for their commitments. Their mission is to empower visionary entrepreneurs who are on the verge of pivotal breakthroughs and revolutionary advancements. By injecting capital, Catalio Capital not only provides monetary resources but also offers strategic guidance, contributing to the growth trajectories of their portfolio companies. The fund seeks to become a crucial part of the entrepreneurial journey, deploying capital effectively to enable technologies and services that aim to redefine industries and improve quality of life globally. Their strategy involves not only identifying promising startups but also ensuring that the companies they invest in have the potential to scale and lead in their respective fields.